An estimated 8 to 16 percent of women in the United States experience chronic vulvar pain at some point, yet many go years without an accurate diagnosis. Vulvodynia is the medical term for chronic vulvar pain lasting more than three months without an identifiable cause. The condition is real, common, frequently dismissed, and increasingly well understood. The treatment toolkit has expanded considerably over the past decade — from topical therapies to pelvic floor work to neuromodulation — and outcomes are generally better when women find a clinician who takes their pain seriously and evaluates it systematically. This article is general health information, not medical advice; work with a qualified clinician for diagnosis and treatment.
What Vulvodynia Is
Vulvodynia is chronic burning, stinging, rawness, or aching of the vulva (the external female genital area) lasting at least three months and not explained by an identifiable cause. ACOG uses the International Society for the Study of Vulvovaginal Disease (ISSVD) classification, which distinguishes localized vulvodynia (typically vestibulodynia, pain at the vaginal opening) from generalized vulvodynia (pain across the entire vulva). The pain can be provoked (triggered by touch, intercourse, tampon insertion, or tight clothing), unprovoked (spontaneous and ongoing), or mixed.
The condition was historically called vulvar vestibulitis, but the terminology changed because true inflammation is not consistently present. Vulvodynia is currently understood as a chronic pain syndrome involving peripheral and central nervous system sensitization rather than an infectious or inflammatory condition. Importantly, MedlinePlus notes that sexually transmitted infections do not cause vulvodynia.
Possible Causes
The cause is not fully understood, and most researchers believe vulvodynia is multifactorial. Proposed mechanisms include nerve hypersensitivity (peripheral sensitization), increased nerve-fiber density in the vulvar tissue, pelvic floor muscle dysfunction, hormonal factors (including hormonal contraception started around the time of pain onset), a possible genetic predisposition affecting inflammation, and central nervous system sensitization in which the nervous system amplifies pain signals.
Contributing triggers may include past yeast or bacterial infections, allergic or irritant reactions to soaps or hygiene products, low-estrogen states (postpartum, breastfeeding, menopause, or some oral contraceptive use), chronic vulvar irritation, and trauma. Many women with vulvodynia also have other chronic pain or sensitivity conditions, including interstitial cystitis, fibromyalgia, irritable bowel syndrome, and migraine, suggesting overlapping pain-processing patterns. Pelvic floor dysfunction is present in a high proportion of women with vulvodynia.
Symptoms
The classic symptoms are burning, stinging, rawness, itching, throbbing, or stabbing pain in the vulva. Women often describe it as feeling “raw,” like “rug burn,” or “constant irritation.” Pain may be worse with touch (provoked) or come and go spontaneously (unprovoked). Common provocations include intercourse, tampon use, tight clothing, sitting for long periods, and bicycle riding.
Physical findings on examination are usually subtle. The vulva often looks normal, though some women have visible erythema (redness) at the vestibule. Q-tip (cotton-swab) testing — gentle touch at specific vestibular points — reproduces the pain in localized vulvodynia. Vaginal discharge, ulcers, and lesions point toward other diagnoses rather than primary vulvodynia and should be evaluated.
Diagnosis
Vulvodynia is a diagnosis of exclusion, meaning it is made only after other causes have been ruled out. A workup ensures no other condition is causing the pain. The clinician will typically rule out infections (yeast, bacterial vaginosis, herpes, trichomoniasis), dermatologic conditions (lichen sclerosus, lichen planus, contact dermatitis), low-estrogen-related vaginal atrophy, vaginal injuries, neurological compression, pelvic floor dysfunction, and pelvic pathology including endometriosis.
The exam commonly includes inspection of the vulvar skin, Q-tip testing of the vestibule for tender points, pelvic floor muscle assessment, urinalysis to rule out a urinary tract infection, and vaginal pH and microscopy or DNA-based testing to rule out infection. A vulvar biopsy is generally reserved for suspicious skin lesions. Consultation with a vulvar specialist or urogynecologist often shortens the diagnostic journey, which the National Vulvodynia Association notes can stretch over years for many women.
Treatment Options
Treatment is layered because no single intervention works for everyone, and plans should be individualized and directed by a clinician. First-line measures include eliminating skin irritants (scented soaps, fabric softeners, and certain sanitary products), using mild cleansers and lubricants, and avoiding tight clothing. Topical therapies your clinician may consider include lidocaine gel or ointment and, in some cases, compounded preparations such as topical estradiol for vestibular tissue or compounded amitriptyline-baclofen blends. Because formulations, strengths, and timing must be tailored to you, these are prescriber-directed — do not attempt to self-dose.
Pelvic floor physical therapy is one of the most effective interventions and is often underused. A trained therapist can identify and release pelvic floor muscle hypertonicity, perform internal trigger-point work, guide the use of vaginal trainers (graduated dilators), and teach diaphragmatic breathing for muscle relaxation. Biofeedback may also help with muscle awareness and relaxation. Most women with vestibulodynia have associated pelvic floor muscle overactivity.
Systemic (oral) medications used for neuropathic pain may include tricyclic antidepressants (such as amitriptyline or nortriptyline) at low doses, gabapentin or pregabalin, and serotonin-norepinephrine reuptake inhibitors. These target neuropathic pain pathways and often take roughly 6 to 8 weeks to show effect; dosing must be started and adjusted by a prescriber, never self-managed, because these medications carry side effects and interactions. Nerve-block injections are an option for some patients. Cognitive behavioral therapy and pain-focused psychotherapy address the cognitive and emotional dimensions of chronic pain. For women with localized vestibulodynia who do not respond to conservative measures, a vestibulectomy (surgical removal of the painful tissue at the vaginal opening) has good long-term outcomes in carefully selected patients.
Sex and Relationships
Painful intercourse can strain relationships and produce secondary anxiety, avoidance, and reduced libido. Couples therapy and sex therapy with clinicians familiar with chronic pelvic pain are valuable adjuncts. Clinician-recommended pre-intercourse topical lidocaine and water-based lubricants help some women, as does abstaining from intercourse during flares while maintaining other forms of intimacy.
Reframing sexual health to emphasize non-penetrative intimacy, communication, and gradual reintroduction of penetration after symptoms improve generally produces better long-term outcomes than pushing through pain. Many women find wellness practices like gentle yoga, mindfulness, and trauma-informed therapy meaningfully helpful as part of a broader plan.
Self-Care and Lifestyle
Day-to-day strategies focus on reducing irritation and managing flares. Wear cotton underwear and loose clothing. Use unscented, dye-free soaps and detergents. Avoid douches, vaginal sprays, and scented sanitary products. Pat dry rather than rubbing. Cool water rinses or cool gel packs can soothe acute flares. Sitz baths with plain water may help some women, though very hot water can sometimes worsen symptoms.
Dietary evidence is limited. Some women report improvement on a low-oxalate diet, but rigorous trials have not consistently confirmed a benefit, so treat it as an individual experiment rather than an established therapy. The broader women’s health conditions guide covers related vulvar and pelvic conditions that often coexist with vulvodynia.
When to See a Doctor
See a clinician for any chronic vulvar pain lasting more than three months, especially if it interferes with intercourse, daily activities, or quality of life. Earlier evaluation is reasonable if the pain is severe or accompanied by other symptoms. Self-treating with antifungals or hygiene changes for months without improvement often delays diagnosis, so seek care sooner rather than later.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience sudden severe pelvic or vulvar pain with fever, signs of severe infection (rapid swelling, foul-smelling discharge, high fever), or a severe acute injury. Vulvodynia itself is a chronic condition and not an emergency, but acute conditions can mimic it and require prompt care.
Frequently Asked Questions
Is vulvodynia all in my head?
No. Vulvodynia is a recognized chronic pain syndrome with measurable changes in nerve density, neural processing, and pelvic floor muscle function. Psychological factors influence chronic pain (as they do for back pain, migraines, and other syndromes), but the pain itself is real and biological.
Can vulvodynia go away on its own?
Some women experience spontaneous improvement, particularly when triggers are identified and removed (such as discontinuing irritating products or addressing pelvic floor dysfunction). For most women, structured, multidisciplinary treatment produces better outcomes than waiting.
Is vulvodynia related to menopause?
It can be. Low estrogen at any life stage (postpartum, breastfeeding, menopause, or with some hormonal contraception) alters vulvar and vaginal tissue and can trigger or worsen symptoms. Clinician-prescribed vaginal estrogen is often part of the treatment plan for postmenopausal women.
Will hormonal birth control make vulvodynia worse?
For some women, yes. Onset of vulvodynia in the months after starting combined oral contraceptives is described in the literature, and a clinician-supervised trial off the pill is reasonable in such cases. The mechanism appears related to suppression of free testosterone and changes in vestibular tissue. Do not stop prescribed contraception without discussing alternatives with your clinician.
The Practical Takeaway
Vulvodynia is real, common, treatable, and routinely missed. The most important first step is an experienced clinician who systematically excludes other causes and then assembles a multidisciplinary plan that may include pelvic floor physical therapy, topical and systemic therapies, and psychological support. Single interventions rarely solve the problem, but layered, individualized treatment reliably improves quality of life for most women. If your provider has dismissed your symptoms or attributed them to anxiety without a thorough exam, seeking a second opinion from a gynecologist, vulvar specialist, or urogynecologist is reasonable.
Medical disclaimer: This article is for general informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Vulvodynia is diagnosed and treated individually by a qualified clinician after other causes are excluded; medications, including topical and nerve-pain agents, must be prescriber-directed and should never be self-dosed. Treatments, timelines, and outcomes vary. Seek emergency care for sudden severe pain with fever, signs of serious infection, or acute injury, and consult a gynecologist, vulvar specialist, or urogynecologist about your specific situation.
Sources
- American College of Obstetricians and Gynecologists (ACOG) — Vulvodynia FAQ, ISSVD classification, and treatment approaches
- MedlinePlus (U.S. National Library of Medicine) — vulvodynia overview, causes, diagnosis (including that STIs do not cause it), and treatment options
- National Vulvodynia Association (NVA) — patient education and diagnostic-delay information
- General clinical literature on pelvic floor physical therapy, neuropathic pain medications, and vestibulectomy outcomes